Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

Rebecca Wilkes's Articles

AMSBIO introduces ALiCE® - a new high yield cell-free protein expression system.

Cell-free protein expression (CFPE) is today used by protein chemists to quickly produce small amounts of proteins when screening DNA libraries. However current technologies are limited and there is a need for higher protein expression yields.

Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies

Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) with a focus on advanced therapy medicinal products (ATMPs) has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency.

Birmingham to lead ground-breaking research into patient experience of cell therapies

Birmingham health researchers, with industry partners including health technology companies Dignio and Datatrial, have been awarded £1.1 million by UK Research & Innovation (UKRI)’s Innovate UK, to investigate patients’ experience of cell and gene therapies.

Chronos Therapeutics Announces Positive Pre-clinical Proof of Concept in MS Fatigue Model

Chronos Therapeutics Announces Positive Pre-clinical Proof of Concept in MS Fatigue Model. Patents for the Fatigue programme awarded in USA and Europe. 

PCI Clinical Services to Showcase Expertise in Phase I Clinical Trials in Australia

Philadelphia, USA – December 3, 2018 PCI Pharma Services (PCI), full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, will showcase its expertise in Phase I Clinical Trials in Australia with a series of West Coast US seminars in January 2019. 

The UK’s first dedicated Vaccines Manufacturing Innovation Centre to be located at The Oxford Science Park

The UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC) will be located at The Oxford Science Park (TOSP), one of the UK's leading parks for science and technology companies, it was announced today

Changes in Leadership at BioCity Group

BioCity Group has today announced that its founding CEO, Dr Glenn Crocker, MBE, will be stepping down at the end of the year and taking up the role of Chairman.

Synpromics named among the top 50 fastest growing technology companies in the UK

Synpromics, the leader in gene control, is delighted to announce that it has been ranked 12th in the Deloitte ‘UK Technology Fast 50’ at the annual awards ceremony in London.

Immunocore and Genentech Expand Partnership to Develop Cancer Immunotherapy MEDICAL

Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore’s immunotherapy for treating solid tumors.

Leading recruitment agency assembles new Operations Team to spearhead its ‘next generation flexible work model’

SRG, the leading science, clinical and engineering recruitment agency, is today announcing a new operational leadership team for Synergy, its flexible science insourcing service dubbed the ‘next generation flexible work model’. 

Pages: Previous12345NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.